Retinopathy of prematurity – Diagnostics – Overview of Information and Clinical Research

Retinopathy of prematurity is an eye condition affecting babies born too early, where abnormal blood vessels develop in the retina. Early detection through specialized eye examinations is crucial, as most babies show no visible signs of the condition until it has progressed significantly.

Introduction: Who Should Undergo Diagnostics

If your baby was born prematurely or at a very low birth weight, they will need eye examinations to check for retinopathy of prematurity. This is not a condition you can detect by looking at your baby at home. The abnormal blood vessels that characterize this disease develop deep inside the eye, in an area called the retina, which is the light-sensitive tissue at the back of the eye that helps us see.^[1]

Babies are considered at risk if they were born before 30 to 31 weeks of pregnancy or if they weighed less than about 3 pounds (approximately 1,500 grams) at birth. These are the babies who most urgently need screening examinations. However, other premature infants may also be screened if their doctor believes they have additional risk factors that make them more vulnerable to developing this eye disease.^[1]^[2]

The timing of when your baby should first be examined depends on how early they were born. Generally, eye doctors will begin screening premature babies in the neonatal intensive care unit while they are still receiving hospital care. If your baby is able to leave the hospital before getting screened, your medical team will schedule an appointment to check their eyes. It is extremely important to attend this appointment, because there are no symptoms you can observe at home that would tell you whether your baby has developed this condition.^[6]^[9]

Additional risk factors that increase the likelihood of developing retinopathy of prematurity include breathing problems that required oxygen therapy, infections, heart conditions, bleeding in the brain, anemia, blood transfusions, and poor weight gain. Babies with these complications are monitored even more carefully, as they face a higher chance of developing severe forms of the disease.^[1]^[4]

⚠️ Important

Retinopathy of prematurity has no visible symptoms that parents can detect at home. Your baby will not appear to be in pain, and their eyes will not look different to you. The only way to know if your baby has this condition is through a specialized eye examination performed by an ophthalmologist. This is why attending all scheduled screening appointments is absolutely essential for protecting your baby’s vision.

Diagnostic Methods for Identifying Retinopathy of Prematurity

The Dilated Eye Examination

The primary method used to diagnose retinopathy of prematurity is a dilated eye examination. This is a specialized test that can only be performed by an ophthalmologist who has experience examining the eyes of infants. The examination involves looking at the inside of your baby’s eye, particularly at the retina and the blood vessels that supply it with oxygen and nutrients.^[1]^[2]

Before the examination begins, your baby’s eyes are dilated with special eye drops. These drops make the pupil (the dark spot in the center of the eye) larger, which allows the doctor to see more clearly into the back of the eye where the retina is located. The drops take some time to work, so there will be a waiting period before the actual examination starts.^[6]

During the examination itself, the eye doctor may use a small tool called a speculum to hold your baby’s eye open. This ensures the doctor can thoroughly examine all areas of the retina. Although this procedure is not painful for your baby, many infants cry during the examination because the sensation is unfamiliar and uncomfortable. The crying does not mean your baby is experiencing pain, but rather that they are reacting to being handled and to the unusual feelings in their eyes.^[9]

The ophthalmologist is looking for specific signs during the examination. Normal, healthy retinas have blood vessels that grow in a particular pattern and stay within the plane of the retina itself. In babies with retinopathy of prematurity, the doctor will see abnormal blood vessel growth. These abnormal vessels may form a line or ridge on the retina, or they may grow upward into the clear gel that fills the eye (called the vitreous humor). The doctor will also check whether the blood vessels appear thick, wavy, or abnormally enlarged, which is a sign called plus disease that indicates more serious progression.^[4]^[6]

Classification of Disease Severity

When an ophthalmologist diagnoses retinopathy of prematurity, they describe the condition using two main classification systems: zones and stages. Understanding these classifications helps doctors communicate about how severe the disease is and where in the eye it is occurring.^[6]

The zone classification refers to the location in the retina where the abnormal blood vessels are growing. Zone 1 is the centermost area of the retina. Zone 2 is the middle area surrounding the center. Zone 3 is the outer edge of the retina. Disease occurring in Zone 1 is more serious because it affects the most critical part of the retina needed for central vision. Disease in Zone 3 is less concerning because it affects only the peripheral (side) areas.^[6]^[9]

The stage classification describes how severe the abnormal blood vessel growth has become. There are five stages, ranging from Stage 1 (the mildest) to Stage 5 (the most severe). In Stage 1, doctors see a thin line on the retina that separates the area with normal blood vessels from the area where vessels have not yet fully developed. In Stage 2, this line develops into a ridge that has height and thickness. Stage 3 is when abnormal, fragile new blood vessels begin growing on this ridge or into the vitreous humor.^[6]^[8]

Stages 4 and 5 are the most serious. In Stage 4, the retina has begun to pull away from its normal position at the back of the eye. This is called partial retinal detachment. In Stage 5, the retina has completely detached. Both of these stages require urgent treatment, though even with treatment, babies at these stages may experience significant vision loss or blindness. This is why doctors prefer to identify and treat the disease during Stage 3, before detachment occurs.^[1]^[8]

Follow-Up Examination Schedule

A single eye examination is rarely sufficient when screening for retinopathy of prematurity. Because the disease can change rapidly and progress from mild to severe in a short time, babies at risk need multiple follow-up examinations scheduled at specific intervals. The ophthalmologist will determine how frequently your baby needs to be checked based on what they see during each examination.^[1]

If the doctor finds no signs of the disease or only very mild changes, they may schedule the next examination for one to two weeks later. If more concerning changes are present, follow-up may be needed within just a few days. It is absolutely critical that you keep all scheduled appointments. The disease can worsen very quickly between examinations, and catching it at the right time makes an enormous difference in whether treatment can prevent vision loss.^[2]

These repeated examinations continue until the retinal blood vessels have finished developing normally, which means the risk period has passed. For some babies, this might mean several weeks or even months of regular eye checks. Although the process can feel overwhelming for parents, especially when your baby is already dealing with the challenges of being born prematurely, these examinations are one of the most important ways to protect your child’s future vision.^[10]

Distinguishing From Other Conditions

Part of the diagnostic process involves making sure that what the ophthalmologist is seeing is actually retinopathy of prematurity and not another eye condition that might look similar. Fortunately, in premature babies, retinopathy of prematurity has very characteristic features that experienced pediatric ophthalmologists can recognize. The pattern of abnormal blood vessel growth, combined with the baby’s history of premature birth and low birth weight, makes the diagnosis relatively straightforward in most cases.^[4]

However, doctors must also be aware that some babies may have other eye problems in addition to or instead of retinopathy of prematurity. Premature infants are at higher risk for several other vision problems as they grow, including nearsightedness, crossed eyes (called strabismus), and lazy eye (called amblyopia). The thorough eye examinations performed to screen for retinopathy of prematurity can also help identify these other conditions early.^[1]^[8]

Diagnostics for Clinical Trial Qualification

When babies with retinopathy of prematurity are being considered for enrollment in clinical trials, they undergo the same fundamental diagnostic procedures described above: dilated eye examinations performed by experienced ophthalmologists. However, clinical trials often have very specific criteria about which babies can participate. These criteria are based on the precise stage and zone of the disease, the presence or absence of plus disease, and sometimes additional factors such as the baby’s gestational age at birth or current weight.^[10]

Clinical trials studying new treatments for retinopathy of prematurity typically focus on babies who have progressed to what doctors call “Type 1 ROP,” which is a specific combination of disease characteristics that indicates high risk for continued progression and vision loss without treatment. To qualify for these trials, the ophthalmologist must carefully document exactly what they observe during the dilated eye examination, including detailed descriptions of the blood vessel abnormalities, measurements of the affected zones, and assessments of plus disease.^[6]

Some research studies may also use specialized imaging techniques to document the appearance of the retina before, during, and after treatment. These images provide objective records of the disease’s progression or regression and help researchers evaluate whether experimental treatments are working. However, these advanced imaging methods are primarily used in research settings and are not part of routine diagnostic screening for all babies at risk of retinopathy of prematurity.^[10]

The strict diagnostic criteria used in clinical trials help ensure that researchers are studying babies with similar disease characteristics, which makes it possible to draw meaningful conclusions about whether a new treatment is effective. If you are considering enrolling your baby in a clinical trial, the research team will explain exactly what diagnostic tests will be performed and what disease characteristics your baby must have to participate.^[2]

Prognosis and Survival Rate

Prognosis

The outlook for babies with retinopathy of prematurity varies greatly depending on the severity of the disease and whether it is detected and treated early. Approximately 90 percent of babies who develop retinopathy of prematurity have mild cases that resolve on their own without causing any lasting damage to their vision. These babies go on to see normally for their age without requiring any treatment beyond careful monitoring.^[2]^[6]

For the remaining 10 percent of babies who develop more severe forms of the disease, the prognosis depends heavily on timely intervention. When retinopathy of prematurity is caught during Stage 3 and treated promptly with laser therapy or medication injections, most babies can avoid the serious complications of retinal detachment. Treatment at this stage gives these infants the best chance of preserving good vision as they grow.^[10]

Babies who progress to Stages 4 or 5, where partial or complete retinal detachment has occurred, face more serious challenges even with treatment. Surgery may be able to reattach the retina, but these babies often experience significant vision loss. Some may be left legally blind despite receiving the best available care. This is why early detection and treatment before detachment occurs is so critically important.^[1]^[8]

Children who had retinopathy of prematurity, even if it resolved without treatment, remain at higher risk for other vision problems as they grow. They are more likely than children born at term to develop nearsightedness, crossed eyes, lazy eye, and even late retinal detachment years after the initial disease has healed. This means that ongoing eye examinations throughout childhood are essential for children with a history of retinopathy of prematurity, allowing doctors to catch and treat any new problems that develop.^[1]^[8]

Survival Rate

In the United States, approximately 14,000 to 16,000 infants develop retinopathy of prematurity each year. Of these babies, about 90 percent have mild disease that does not require treatment. Approximately 1,100 to 1,500 infants develop disease severe enough to need medical treatment such as laser therapy or injections. Despite the availability of these treatments, about 400 to 600 infants per year become legally blind from retinopathy of prematurity.^[2]^[6]

These numbers reflect both the success and the limitations of current screening and treatment approaches. The vast majority of babies at risk are successfully monitored, and most never require treatment at all. Among those who do need treatment, many have their vision preserved. However, a small but significant number still experience severe vision loss despite receiving care, highlighting the importance of continued research into better treatments and prevention strategies.^[2]

The prognosis also depends on factors beyond just the medical care received. Babies who are born at extremely low gestational ages or with very low birth weights face greater overall health challenges, and the presence of other medical complications such as infections, heart problems, or brain bleeds can worsen the outlook for their vision as well as their general health. However, with modern neonatal intensive care and careful ophthalmologic monitoring, even the smallest and most premature babies now have better chances than ever before of surviving and maintaining functional vision.^[5]^[10]

#1 Clinical Trials Search in Europe